uniQure Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:QURE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Sep 22SellUS$43,007Alexander KutaIndividual2,306US$18.65
16 Jun 22SellUS$22,268Christian KlemtIndividual1,687US$13.20
16 Jun 22SellUS$100,066Pierre CalozIndividual7,575US$13.21
28 Feb 22SellUS$26,753Robert GutIndividual1,602US$16.70
28 Feb 22SellUS$56,932Alexander KutaIndividual3,405US$16.72
28 Feb 22SellUS$68,460Christian KlemtIndividual4,075US$16.80
28 Feb 22SellUS$24,753Ricardo DolmetschIndividual1,484US$16.68
28 Feb 22SellUS$170,257Matthew KapustaIndividual10,195US$16.70
28 Feb 22SellUS$10,055Paula SoteropoulosIndividual596US$16.87
28 Feb 22SellUS$10,053Madhavan BalachandranIndividual602US$16.70
28 Feb 22SellUS$10,053David MeekIndividual602US$16.70
28 Feb 22SellUS$10,053Jeremy SpringhornIndividual602US$16.70
28 Feb 22SellUS$10,056Jack KayeIndividual600US$16.76
28 Feb 22SellUS$13,229Leonard PostIndividual795US$16.64
26 Jan 22SellUS$53,069Alexander KutaIndividual2,945US$18.02
26 Jan 22SellUS$197,308Matthew KapustaIndividual10,901US$18.10
26 Jan 22SellUS$71,453Christian KlemtIndividual3,963US$18.03
26 Jan 22SellUS$42,546Robert GutIndividual2,348US$18.12

Insider Trading Volume

Insider Buying: QURE insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of QURE?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders443,2850.9%
General Public1,007,8062.2%
Public Companies2,388,1085.1%
Hedge Funds9,556,23320.4%
Institutions33,419,67771.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 77.13% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.46%
BlackRock, Inc.
4,898,640$125.8m13.95%no data
9.1%
Point72 Asset Management, L.P.
4,260,993$109.5m11.52%0.27%
6.54%
State Street Global Advisors, Inc.
3,063,265$78.7m29.52%no data
6.2%
Nantahala Capital Management, LLC
2,901,929$74.6m-6.11%6.78%
5.82%
FMR LLC
2,724,757$70.0m-2.22%0.01%
5.11%
PFM Health Sciences, LP
2,393,311$61.5m7.02%2.45%
5.1%
Bristol-Myers Squibb Company
2,388,108$61.4m0%no data
3.41%
OrbiMed Advisors LLC
1,597,000$41.0m82.55%0.72%
3.06%
The Vanguard Group, Inc.
1,434,004$36.8m10.94%no data
2.93%
683 Capital Management, LLC
1,373,600$35.3m1.37%2.95%
2.92%
Holocene Advisors, LP
1,369,032$35.2m101.14%0.21%
1.91%
Morgan Stanley, Investment Banking and Brokerage Investments
893,621$23.0m-29.73%no data
1.8%
Aquilo Capital Management, LLC
841,471$21.6m-13.38%9.97%
1.51%
Macquarie Investment Management Business Trust
706,510$18.2m-0.09%0.02%
1.41%
J.P. Morgan Asset Management, Inc.
657,929$16.9m-10.38%no data
1.17%
Forbion Capital Partners B.V.
546,166$14.0m0%10.07%
1.16%
SV Health Investors, LLC
544,500$14.0m21.95%3.69%
1.11%
Tekla Capital Management LLC
521,693$13.4m0%0.5%
1.08%
Columbia Management Investment Advisers, LLC
505,165$13.0m5.41%no data
0.98%
Goldman Sachs Group, Investment Banking and Securities Investments
459,355$11.8m14%0.01%
0.97%
Adage Capital Management, L.P.
455,000$11.7m102.22%0.03%
0.92%
Integral Health Asset Management, LLC
433,000$11.1m22.63%2.28%
0.88%
Norges Bank Investment Management
411,371$10.6m0%no data
0.85%
Geode Capital Management, LLC
396,187$10.2m10.45%no data
0.71%
BNY Mellon Asset Management
333,334$8.6m19.49%no data